CaseA 66-year-old woman with Parkinson's disease (PD) was scheduled for insertion of electrodes for deep brain stimulation (DBS). She was right handed, English speaking, and of normal intelligence. Her memory was good but a marked tremor interfered with her quality of life. Her current medications, levodopa (L-dopa) (Sinemet), bromocriptine (Parlodel), selegiline (Eldepryl), pramipexole (Mirapex), and amantadine (Symmetrel), afforded only fair movement control. She was very depressed and sertraline hydrochloride (Zoloft) had been prescribed. She had a history of hypertension treated with hydrochlorothiazide and diltiazem and type 2 diabetes controlled with diet and glyburide.'